{"id":"W2024643527","doi":"10.1007/s10227-005-0117-0","title":"Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II","year":2005,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"National Cancer Institute; Genentech","keywords":"Efalizumab; Medicine; Adverse effect; Placebo; Psoriasis; Clinical trial; Incidence (geometry); Dermatology; Internal medicine; Plaque psoriasis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474604,0.0008912809,0.002814437,0.002293133,0.000212808,0.0007876254,0.0008953349,0.0008650338,0.002109606],"category_scores_gemma":[0.002086044,0.0003969341,0.0009662815,0.002861153,0.0004576116,0.0007279745,0.0003341938,0.0006815707,0.0007227833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005646037,"about_ca_system_score_gemma":0.001087014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001242896,"about_ca_topic_score_gemma":0.002050041,"domain_scores_codex":[0.9994673,0.0001363504,0.000155587,0.00006762551,0.000152255,0.00002090391],"domain_scores_gemma":[0.998633,0.0006899775,0.0004111246,0.00002525223,0.0001966754,0.00004405374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003832124,0.00006553891,0.0004656643,0.1204795,0.0006762972,0.0001788106,0.00006708365,0.0002317729,0.001425201,0.0004237532,0.01776269,0.8578405],"study_design_scores_gemma":[0.0006730779,0.001855743,0.01494855,0.1146565,0.006549546,0.006713883,0.0002938867,0.0004391822,0.002155032,0.002491927,0.8491468,0.00007581447],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000126152,0.9995093,0.00004444585,0.00007994464,0.00004877568,0.00001097574,0.00001651052,0.000002491607,0.0001613919],"genre_scores_gemma":[0.001466262,0.9979932,0.0001367205,0.0001550199,0.00006350094,0.00001835244,0.00003082812,0.000001244936,0.0001349854],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002814437,"threshold_uncertainty_score":0.007798553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07264368308476009,"score_gpt":0.3433263525560137,"score_spread":0.2706826694712536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}